Form 10-Q · Quarterly report
Bunge Global 10-Q, filed Oct 29, 2026
- Filed
- CIK
- 0001996862
- Accession no.
- 0001628280-26-068130
Summary
Bunge Global reported third-quarter 2026 net income attributable to shareholders of $318 million, or $1.64 per diluted share, up from $166 million, or $0.84, a year earlier, as net sales rose 7% to $23,804 million. For the first nine months, net income attributable to Bunge shareholders was $1,064 million, or $5.45 per diluted share, versus $721 million, or $4.60, as higher segment EBIT was partly offset by increased interest expense from debt financing the Viterra Acquisition and higher working capital.
Key points
- Third-quarter 2026 total EBIT was $667 million, up from $403 million a year earlier; nine-month total EBIT was $1,911 million, up from $1,269 million.
- Third-quarter cost of goods sold included $66 million of impairment charges and $16 million of hedge losses tied to the announced sale of two sugarcane mills in Brazil, plus $10 million of charges from Ukraine-Russia war-related inventory damage.
- Nine-month interest expense rose 42% to $586 million, driven by higher debt to finance the Viterra Acquisition and working capital requirements.
- Foreign exchange losses were $183 million for the first nine months of 2026, compared with a $14 million gain a year earlier.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
From the filing
ITEM 2. MANAGEMENT’S DISCUSSION Executive Summary Net income (loss) attributable to Bunge shareholders - For the three months ended September 30, 2026, Net income attributable to Bunge shareholders was $318 million, an increase of $152 million compared to $166 million, for the three months ended September 30, 2025. For the nine months ended September 30, 2026, Net income attributable to Bunge shareholders was $1,064 million, an increase of $343 million, compared to $721 million for the nine months ended September 30, 2025. …
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.